Treatment of AL Amyloidosis with Peripheral Edema and Nephrotic-Range Proteinuria
This protocol addresses AL amyloidosis in patients presenting with nephrotic-range proteinuria and peripheral edema — a pattern consistent with renal involvement that requires specific management considerations.
The defining features of this sub-population are nephrotic-range proteinuria together with peripheral edema. These findings drive the therapeutic priorities outlined in this protocol.
Patients in this setting are generally managed with a diuretic-based strategy combined with fluid and salt restriction. Whether certain additional agents are appropriate depends on further clinical factors — specifics are in the full protocol.
Full agent selection, sequencing criteria, and complete regimen details are available via the structured protocol below.
References
DOI: 10.1200/OP.22.00396
- Patients with nephrotic range proteinuria, and peripheral edema, are usually treated with loop diuretics and fluid and salt restriction.
- In the absence of heart failure, renin-angiotensin system blockers can sometimes be used; however, they are not the preferred agents as their role in AL amyloidosis is not yet clear.